BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Onyx Scientific Limited Clinches Cancer Research UK Contract


5/9/2011 3:02:16 PM

The UK’s leading cancer charity has awarded a major drug development and manufacturing project to chemistry experts Onyx Scientific.

Cancer Research UK has selected the UK-based active pharmaceutical ingredient (API) manufacturer to develop the chemistry and perform the GMP synthesis of the API for use in a Phase 1 clinical trial.

The team at Cancer Research UK initially approached its preferred suppliers with its requirements and a proposed development route. After analysing the charity’s needs in more detail, the technical team at Onyx Scientific has improved the synthetic methodology as well as suggesting an alternative route, which long term will potentially help make the project more efficient and cost effective.

Dr Nigel Westwood, drug supply manager at Cancer Research UK, said: “Having had a very positive experience of using Onyx Scientific’s process development and GMP manufacturing services in the past, they seemed like a strong candidate for this important project.

“Despite the fact that Cancer Research UK had to change suppliers at such a critical stage, Onyx Scientific still expect to bring the project in on time and on budget. Given their expertise in chemistry and ability to deliver, we believe they are perfect fit for the project,” added Dr Westwood.

Onyx Scientific provides outsourced facilities and expertise to help pharmaceutical and biotech companies accelerate drug candidates from discovery, through development, into Phase I/II GMP API manufacturing. The Cancer Research UK project is one of the biggest projects in the firm’s history and is expected to take around seven months to complete.

Denise Bowser, commercial director at Onyx Scientific, said: “We are delighted to be working again with the team at Cancer Research UK on this major project as it clearly indicates confidence in our technical expertise, customer service and ability to deliver on time.

“The input we have had to date has been positive and has no doubt demonstrated our commitment to go the extra mile for clients by meeting their requirements as efficiently as possible.”

Onyx Scientific has worked on contract chemistry, development and production projects for over 150 organisations across the world. It now operates as a preferred partner of around half of the world’s top 10 big pharma firms and has achieved a 96% customer loyalty rate based on repeat projects.

For more information about Onyx Scientific please visit www.onyx-scientific.com and follow Onyx at www.twitter.com/onyxscientific1

Onyx Scientific Ltd offers contract research, custom synthesis, GMP manufacturing for clinical trials, polymorphism, salt selection and other services plus novel fine chemicals based on proprietary technology.

Media enquiries:

For further information, images and interview opportunities, please contact:

Raman Sehgal

raman@ramarketingpr.com




   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->